Skip to the page

Data / Drug companies / Ax Pharmaceutical Corp

Ax Pharmaceutical Corp: 123 products in the FDA NDC directory, labeler code 73377

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Ax Pharmaceutical Corp (labeler code 73377) lists 123 products in the FDA National Drug Code Directory. By type: 123 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on October 28, 2026.

The request: Watch Ax Pharmaceutical Corp (FDA labeler code 73377): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
73377
Products in commercial distribution
123
Packages
404
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule III 3, Schedule IV 1, Schedule V 1
Started marketing in the last 12 months
21
Products with a marketing end date set
9
Earliest marketing start
January 24, 2020
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients for compounding12198.4%
Bulk ingredients21.6%

Products by type

TypeProductsShare
Bulk ingredients123100%

Dosage forms

Dosage formProductsShare
Powder12198.4%
Suspension10.8%
Oil10.8%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Dapoxetine hcl73377-374PowderBulk ingredients for compoundingOctober 28, 2026
Atorvastatin calcium trihydrate73377-372PowderBulk ingredients for compoundingOctober 2, 2026
Testosterone cypionate73377-370PowderBulk ingredients for compoundingSeptember 3, 2026
Testosterone undecanoate73377-369PowderBulk ingredients for compoundingSeptember 3, 2026
Betahistine dihydrochloride73377-368PowderBulk ingredients for compoundingAugust 13, 2026
Zinc pyrithione73377-364SuspensionBulk ingredients for compoundingJuly 30, 2026
Phenoxybenzamine hcl73377-363PowderBulk ingredients for compoundingJuly 20, 2026
Sirolimus73377-360PowderBulk ingredients for compoundingJuly 3, 2026
Paroxetine hydrochloride hemihydrate73377-359PowderBulk ingredients for compoundingJune 26, 2026
Bupropion hcl73377-358PowderBulk ingredients for compoundingJune 17, 2026
Orlistat73377-356PowderBulk ingredients for compoundingMay 27, 2026
Levocarnitine73377-355PowderBulk ingredients for compoundingMay 27, 2026
Alprostadil73377-354PowderBulk ingredients for compoundingMay 22, 2026
Podophyllum resin73377-348PowderBulk ingredients for compoundingMarch 27, 2026
Celecoxib73377-345PowderBulk ingredients for compoundingFebruary 6, 2026
Efinaconazole73377-344PowderBulk ingredients for compoundingFebruary 4, 2026
Leucovorin calcium73377-342PowderBulk ingredients for compoundingJanuary 8, 2026
Telmisartan73377-340PowderBulk ingredients for compoundingDecember 29, 2025
Nicotinamide adenine dinucleotide73377-339PowderBulk ingredients for compoundingDecember 3, 2025
Tadalafil73377-338PowderBulk ingredientsNovember 20, 2025
Sodium phenylbutyrate73377-337PowderBulk ingredients for compoundingNovember 11, 2025
Olopatadine hci73377-336PowderBulk ingredients for compoundingOctober 28, 2025
Mycophenolate mofetil73377-335PowderBulk ingredients for compoundingOctober 22, 2025
Mometasone furoate73377-334PowderBulk ingredients for compoundingOctober 9, 2025
Albendazole73377-333PowderBulk ingredients for compoundingSeptember 3, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.